Source: The New Indian Express
The Covid-19 pandemic has caused a great deal of anxiety for the lungs.
Since the start of the second wave, information on lung health has been increasingly distributed and misinformation is becoming more prevalent. There is spreading misinformation among subjects, mainly for asthma patients.
According to the Global Burden of Disease Report, 93 million people in India suffer from respiratory problems. Of these, 37 million are battling asthma. India is the capital of asthma, accounting for 11.1 per cent of asthma deaths globally and India accounts for 42 per cent of asthma deaths globally.
Dust, cold, animal fur, viruses, air pollutants, emotional disturbances are also causes of asthma.
It is a misconception that ingestion of long-term drugs can be a cure for inhalation therapy. Asmita A. Mehta.
Although there is no permanent cure for asthma, it is possible to live a normal life. Proper treatment and asthma management are therefore crucial.
The effect of inhalation therapy is to reach the lungs and the effect begins to work immediately. So Global Strategy for Asthma Management Guidelines
They recommend inhalation therapy.
Asthma requires long-term medications. Many patients do not use the medication they are given most of the time. Or inadequate use of inhalers. This stops the treatment in half.
Asthma & Covid
- Dr. Krishnan said that among the Kovid-19 fears, asthma sufferers have some guidelines to follow. Recommended by Asmita.
- Continue the inhaler medications given by the doctor,
- Patients should consult their doctor when asthma increases
- When asthma increases, nebulizers should be avoided as much as possible, since there is a risk of Covid-19 virus transmission. Use only on medical advice
- Prioritize the use of Pressurized Metered-Dose Inhalers (PMDIs) by Spacer.
- Do not share spacers with anyone, as there is a risk of Covid-19